E-LIB Suche - Ergebnisse für: Mrowietz, U

1

Efficacy and safety of apremilast in patients with limited ..:

Mrowietz, U ; Barker, J ; Conrad, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.18689. , 2023

Link: https://serval.unil.ch/n..

2

PsoBest: Aktueller Stand, Patientenprofile und Auswirkungen..:

Schaeffer, L ; Sorbe, C ; Rustenbach, SJ...
http://dx.doi.org/10.3205/22dkvf417. , 2022

Link: https://doi.org/10.3205/..

3

Merkmale von Patient*innen mit Psoriasis-Arthritis in derma..:

Kühl, L ; Lindner, L ; Augustin, M...
http://dx.doi.org/10.3205/22dkvf039. , 2022

Link: https://doi.org/10.3205/..

4

Long-term efficacy and safety of brodalumab in moderate-to-..:

Reich, K ; Iversen, L ; Puig, L...
https://pure.au.dk/portal/en/publications/40ad08a7-6b04-49b0-818a-06ef46c1a798. , 2022

Link: https://pure.au.dk/porta..

5

Bimekizumab response maintenance through two years of treat..:

Strober, B ; Asahina, A ; Mrowietz, U...
issn:0560-2076. , 2021

Link: http://hdl.handle.net/11..

6

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, A ; Smith, C ; Spuls, P.I...
Journal of the European Academy of Dermatology and Venereology, 0926-9959, 2021, 35:2, s. 281-317. , 2021

Link: http://urn.kb.se/resolve..

7

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, A ; Smith, C ; Spuls, P. I...
https://pure.au.dk/portal/da/publications/euroguiderm-guideline-on-the-systemic-treatment-of-psoriasis-vulgaris--part-2(e2e42765-2bd8-42ba-8dc3-973f4d8cc7d2).html. , 2021

Link: https://pure.au.dk/porta..

8

PsoBest: Aktueller Stand und Auswirkungen auf die Gesundhei..:

Sorbe, C ; Kühl, L ; Schade, U...
http://dx.doi.org/10.3205/21dkvf117. , 2021

Link: https://doi.org/10.3205/..

9

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, A ; Smith, C ; Spuls, P. I...
10.1111/jdv.16926. , 2021

Link: http://hdl.handle.net/10..

10

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, A ; Smith, C ; Spuls, P. I...
10.1111/jdv.16915. , 2021

Link: http://hdl.handle.net/10..

11

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, A ; Smith, C ; Spuls, P I...
https://boris.unibe.ch/164029/. , 2021

Link: https://boris.unibe.ch/1..

12

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, Alexander ; Smith, Colin ; Spuls, Phyllis I...
Journal Of The European Academy Of Dermatology And Venereology. -35 : 2 (2021), p. 281-317. -J. Eur. Acad. Dermatol. Venereol. - 0926-9959. , 2021

Link: http://hdl.handle.net/24..

13

Network meta‐analysis of biologic treatments for psoriasis ..:

Mrowietz, U ; Warren, R.B ; Leonardi, C.L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248394/. , 2021

Link: http://www.ncbi.nlm.nih...

14

EuroGuiDerm Guideline on the systemic treatment of Psoriasi..:

Nast, Alexander ; Smith, C ; Spuls, P. I...
https://refubium.fu-berlin.de/handle/fub188/34097. , 2021

Link: https://refubium.fu-berl..

15

Association of clinical and demographic factors with the se..:

Benzian-Olsson, N ; Dand, N ; Chaloner, C...
JAMA Dermatology. , 2020

Link: http://hdl.handle.net/10..